Business

Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D., Ph.D., MHSc, MBA, to its Board of Directors, effective February 9, 2026.

articleLabcorp Holdings Inc.February 9, 20262/company/laboratory-corporation-of-america-holdings/news/labcorp-appoints-john-h-sampson-133000649
Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors

About this update from Labcorp Holdings Inc.

[{"type":"text","content":"BURLINGTON, N.C., Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D., Ph.D., MHSc, MBA, to its Board of Directors, effective February 9, 2026.","length":276,"tagName":"p"},{"type":"image","alt":"Dr. John H. Sampson","displaySize":"","headline":null,"caption":"Dr. John H. Sampson","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":389,"url":"https://media.zenfs.com/en/prnewswire.com/b2f2a0fe0af5d25c57c1a6bd9368ee55"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/lgDmhEjmSZuLSt_ML_33gQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTY4NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b2f2a0fe0af5d25c57c1a6bd9368ee55","width":400,"height":389}},"href":"https://mma.prnewswire.com/media/2889486/Dean_Sampson_Headshots_2024___7_1___002.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Sampson serves as vice chancellor for health affairs and dean of the University of Colorado Anschutz School of Medicine at the CU Anschutz medical campus. As a nationally recognized neurosurgeon, physician-scientist and academic leader, Dr. Sampson brings extensive experience spanning clinical care, biomedical research, medical education and large-scale health system leadership. He also has deep expertise in oncology, neuroscience, women's health and personalized medicine which aligns with Labcorp's strategic areas of focus.","length":547,"tagName":"p"},{"type":"text","content":""John is widely respected as a leader in academic medicine, clinical practice, health system strategy and research," said Adam Schechter, Chairman and Chief Executive Officer of Labcorp. "His expertise will help advance Labcorp's strategy across diagnostics and drug development and enhance the value we deliver to customers."","length":360,"tagName":"p"},{"type":"text","content":"Before joining the CU Anschutz School of Medicine, Dr. Sampson held senior leadership roles at Duke University Health System, where he served as senior vice president and led the Duke Health Integrated Practice. He is a practicing neurosurgeon, a member of the National Academy of Medicine, and has authored nearly 300 peer-reviewed publications, with a long track record of r...

More updates from Labcorp Holdings Inc.

LabcorpJohn H. SampsonCU Anschutz medical campusSampsonbiomedical researchNYSEglobal leaderdrug developmenthealth system